PR Newswire Clinical TrialsOriginal article
Intus Bio-Led Consortium Receives $2.7M NIH/NCI Fast-Track Award for Bacteria-Based Early-Onset Colorectal Cancer Test
Bacteria-Based Early-Onset Colorectal Cancer TestPositive
AI Analysis
Summary
Intus Bio-led consortium received a $2.7M NIH/NCI Fast-Track Award to develop a non-invasive bacterial microbiome-based screening test for early-onset colorectal cancer in collaboration with four major research institutions.
Outcome Details
$2.7M NIH/NCI Fast-Track Award
Importance:5/10
Sentiment:
0.60
NIH fundingNCI grantcolorectal cancerearly-onsetmicrobiomediagnostic testnon-invasive screeningconsortium
Read the original article
Published by PR Newswire Clinical Trials on September 11, 2026 12:30 PM